The Director at the Cancer Alliance of South Africa, Salome Meyer is urging the country to turn its commitment to women’s rights into meaningful action by accelerating efforts to eliminate cervical cancer this Women’s Month.
Cervical cancer remains the second-most common cancer among South African women between the ages of 15 and 44, and is the leading cause of cancer-related deaths in this age group.
Nearly 6,000 women lose their lives to the disease annually, even though more than 95% of cases are caused by the human papillomavirus (HPV), which can be prevented through vaccination and detected early through regular screening.
“Women’s Month is not only a time to celebrate women, it is a time to protect their health and their future. No woman should lose her life to a disease that is both preventable and treatable,” Meyer said.
South Africa has committed to the World Health Organization’s (WHO) 90-70-90 targets, which aim to eliminate cervical cancer as a public health problem. These goals include ensuring that 90% of girls are fully vaccinated against HPV by the age of 15, 70% of women are screened at least twice in their lifetime, and 90% of women diagnosed with pre-cancer or cervical cancer receive appropriate treatment.
Health Minister Dr Aaron Motsoaledi has previously described cervical cancer elimination as “a matter of social justice and gender equality”, reinforcing the country’s commitment to improving women’s health outcomes.
Recent progress includes the Department of Health’s decision to expand its school-based HPV vaccination programme to independent and private schools, as well as adopting single-dose vaccination guidelines to increase access. However, public health advocates argue that policy alone is not enough.
“One woman dies from cervical cancer every 67 minutes in South Africa. These are not just statistics; they are mothers, daughters, sisters, colleagues and friends. We cannot afford to delay action,” Meyer said.
The burden of the disease is particularly severe for women living with HIV, who are six times more likely to develop cervical cancer than women without HIV. With sub-Saharan Africa carrying the overwhelming majority of cases involving both HIV and cervical cancer, experts say prevention efforts must be better integrated into existing HIV care services.
Countries such as Botswana and Eswatini have already strengthened their cervical cancer prevention strategies by incorporating higher-valency HPV vaccines and dedicated prevention pathways into their healthcare guidelines, providing examples of how integrated care can improve outcomes.
While vaccination and screening remain the cornerstones of prevention, advocates say misinformation, stigma and unequal access to healthcare continue to prevent many women from receiving potentially life-saving services.
Meyer believes civil society organisations play a crucial role in reaching communities that formal healthcare systems often struggle to access.












